Target intelligence / Profile preview

30S ribosomal subunit A-site decoding region (30S A-site)

Target
30S A-site
Molecular classification
Ribosomal RNA, Ribonucleoprotein complex, Ribosome
01

Overview

The 30S ribosomal subunit A-site decoding region is a critical functional domain within the bacterial ribosome responsible for ensuring the fidelity of protein synthesis (PubMed: 11014182). Located primarily within the 16S ribosomal RNA (rRNA), this region facilitates the specific interaction between the mRNA codon and the cognate aminoacyl-tRNA anticodon (NCBI: NBK22554). During translation, the decoding center undergoes conformational changes, specifically the flipping out of conserved adenine residues (A1492 and A1493 in E. coli), to monitor the accuracy of base pairing (PubMed: 11136711). This site is a major target for several classes of antibiotics, most notably aminoglycosides and tetracyclines (StatPearls: NBK541077). Aminoglycosides bind to the A-site and stabilize the active conformation regardless of codon-anticodon complementarity, leading to the incorporation of incorrect amino acids (mistranslation) and bacterial cell death (PubMed: 10542187). Tetracyclines, conversely, physically block the A-site to prevent the entry of aminoacyl-tRNA, thereby halting protein elongation (PubMed: 11130715). Because the bacterial A-site differs structurally from the human mitochondrial and cytosolic ribosomes, it allows for selective toxicity, though clinical use is often limited by potential side effects like ototoxicity and nephrotoxicity (PubMed: 16272181).

Other names
Bacterial decoding center16S rRNA A-siteAminoacyl-tRNA binding siteDecoding region of the 30S subunitRibosomal decoding site
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 16S rRNA within the 30S subunit; aminoglycosides induce mRNA misreading by stabilizing the flipped-out state of A1492 and A1493 (PubMed: 11136711), while tetracyclines sterically block the A-site to prevent aminoacyl-tRNA binding (PubMed: 11130715).

03

Biological functions

Protein synthesismRNA decodingTranslation fidelitytRNA selection
04

Disease associations

Infection
05

Safety considerations

Ototoxicity (vestibular and cochlear damage)Nephrotoxicity (acute kidney injury)Neuromuscular blockadeDevelopment of multidrug resistance (MDR)
06

Interacting drugs

Gentamicin

13 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)16S rRNA gene mutationsAminoglycoside-modifying enzymes (AMEs)16S rRNA methyltransferases (e.g., ArmA, RmtB)

Beyond the preview

Go deeper on 30S ribosomal subunit A-site decoding region (30S A-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 30S ribosomal subunit A-site decoding region (30S A-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call